merck & co. inc. (MRK:New York)
Executive Profile*
Thomas Henry GlocerDirector, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility Committee, Merck & Co. Inc. |
| Age | Total Calculated Compensation | This person is connected to 92 board members in 6 different organizations across 6 different industries. See Board Relationships |
| 52 | $260,000 |
Background*
Mr. Thomas Henry Glocer, Tom served as the Chief Executive Officer of Thomson Reuters UK Ltd. from July 2001 to January 1, 2012. Mr. Glocer also served as the Chief Executive Officer of Thomson Reuters Corporation from 2008 to January 1, 2012. He joined Reuters Group Plc in 1993 and served as its Vice President and Deputy Counsel of Reuters America and served as an Executive Vice President and General Counsel, Reuters America Holdings since 1995. He served as Chief Executive ...
Corporate Headquarters*One Merck DriveWhitehouse Station, New Jersey 08889-0100 United States Phone: 908-423-1000 Fax: 908-735-1253 Board Members Memberships*Director 2000-2011 Former Chief Executive Officer and Executive Director 2000-2011 Former Chief Executive Officer and Director 2001-Present Senior Director and Member of Nominating Committee 2007-Present Director, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility Committee
Education*JD Yale Law School Bachelor's Degree Columbia University
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| MRK:US | $47.16 USD | -0.17 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Marijn E. Dekkers Ph.D. | Chairman of Management Board and Chief Executive Officer Bayer AG | €3.0M |
| Andrew Philip Witty | Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee GlaxoSmithKline plc | 1.9M GBP |
| Christopher A. Viehbacher | Chief Executive Officer, Director and Member of Strategy Committee Sanofi | €3.5M |
| Severin Schwan | Chief Executive Officer and Director Roche Holding AG | SFr.6.5M |
| Jean-Paul Agon | Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee L'Oreal SA | €3.9M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Chicago, IL | Merck GroupPosted: May 21
- Billerica, MA | Merck GroupPosted: May 25
- Boston, MA | Merck GroupPosted: May 25
- Boston, MA | Merck GroupPosted: May 21
Sponsored Financial Commentaries
Sponsored Links
To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








